A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease (Q39218023)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q66385451)
(P304) 986-993
(P407) (Q1860)
(P433) 3
(P478) 105
(P577) Thursday, September 30, 2004
(P921) (Q181600)
(Q29496)
(Q264118)
(Q55779816)
(P1433) (Q885070)
(P1476) "A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease" (language: en)
(P2093) Walter Fiedler
Hubert Serve
Michael Schwittay
Oliver G Ottmann
Anne-Marie O'Farrell
Carlo L Bello
Randy Allred
William C Manning
Julie M Cherrington
Sharianne G Louie
Weiru Hong
Nicoletta M Brega
Giorgio Massimini
Paul Scigalla
Wolfgang E Berdel
Dieter K Hossfeld
other details